$ Value
$0
Shares
35,578
Price
$0
Filed
May 9
Insider
Name
Hayden Phillip Brady
Title
Chief Financial Officer
CIK
0001938940
Roles
Transaction Details
Transaction Date
2025-05-08
Code
G
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
On October 9, 2024, the Company granted Brady Hayden 152,500 restricted stock units ("RSUs") under the 2020 Omnibus Incentive Plan (the "Award"). Each RSU represents a contingent right to receive one share of common stock. On May 7, 2025, the Board determined that the Company met the first performance condition of the Award, by achieving more than $4,500,000 in adjusted free cash flow since October 1, 2024, and thereby triggering the vesting of one-third of the Award, or 50,833 RSUs. The second performance condition that would trigger vesting and distribution of the remaining two-thirds of the Award is confirmation by the Board that the Company achieved at least $9 million in adjusted free cash flow during the period October 1, 2024 through September 30, 2025. In the event that the second performance condition is not met, the remaining RSUs will be cancelled. Vesting is subject to continued employment on the vesting date. | Represents the withholding of shares of the Company's common stock for tax purposes in connection with the vesting of restricted stock units previously granted, which does not constitute an actual sale or other open market transaction. | Reflects the exempt transfer of 35,578 shares from Mr. Hayden to P. Brady Hayden Revocable Trust on May 08, 2025 for no consideration. The reporting person is trustee of the trust, and the reporting person is the sole beneficiary of the trust. The reporting person remains the beneficial owner of the securities held by the trust.
Filing Info
Hayden Phillip Brady's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-10 | CURI | A | $0 |
| 2026-01-02 | CURI | ▼ | $66K |
| 2025-12-15 | CURI | ▼ | $9K |
| 2025-11-17 | CURI | ▼ | $6K |
| 2025-11-12 | CURI | G | — |
| 2025-11-12 | CURI | G | — |
| 2025-11-11 | CURI | M | — |
| 2025-11-11 | CURI | M | — |
| 2025-11-06 | CURI | ▼ | $68K |
| 2025-09-02 | CURI | ▼ | $74K |
Other Insiders at CURI (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| HUBERMAN JONATHAN | — | — | 2026-02-04 |
| HENDRICKS JOHN S | — | — | 2026-02-04 |
| Blank Matthew | — | — | 2026-02-04 |
| Nikzad Michael | — | — | 2026-02-04 |
|
Stinchcomb Clinton Larry
President and CEO
|
— | — | 2026-03-11 |
| Hendricks Elizabeth Ann | — | — | 2026-02-04 |
| Keeley Patrick J. | — | — | 2026-02-04 |
| Hendricks Andrew | — | — | 2026-02-04 |
|
Hayden Phillip Brady
Chief Financial Officer
|
— | — | 2026-02-10 |
|
Reed Rebecca R
Gen Counsel
|
— | — | 2026-02-10 |
|
Vilade John Thomas Jr
Chief Commercial Officer
|
— | — | 2026-02-10 |